Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions
Abstract
A novel method for the analysis of drug receptor interactions has been developed and used to explore mechanisms involved in the binding of 4-piperidyl oxazole antagonists to alpha1a-, alpha1b- and alpha1d-adrenoceptors. The method exploits affinity data for a series of organic chemical compounds binding to wild-type and artificially mutated receptors. The receptor sequences and compounds are assigned predictor variables that are correlated to the measured pharmacological activities using partial least-squares projections to latent structures. The predictor variables consist of one descriptor block derived from the chemical properties of the receptors' primary amino acid sequences and another descriptor block derived from the chemical properties of the organic compounds. The cross-terms generated from the two descriptor blocks are also derived. Using this approach, very sturdy models were generated describing the interactions of the chemical compounds with the receptors. Models are useful to predict binding affinity and receptor subtype selectivity of compounds prior to their synthesis, and may find use in rational drug design. Moreover, models also give quantitative information about the interactions of the amino acids of the receptors with the ligands, thereby giving an insight into the molecular mechanisms involved in ligand binding.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PCM was used to predict ligand interactions with wild-type and mutated α-adrenoceptors, demonstrating superior predictivity compared to conventional QSAR methods.
“For instance, this approach was used to predict ligand interactions with wild-type and mutated α-adrenoceptors where it has demonstrated superior predictivity in comparison with conventional QSAR methods.118”
From QSAR without borders (2020) · cites this paper as [118]
Cites
Experimental design and optimization
Lundstedt, T., Seifert, E., Abramo, L., Thelin, B., Nyström, Å., Pettersen, J., & Bergman, R. (1998) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/s0169-7439(98)00065-3 · Cited by 1,162 · see citing works
Self-citationSandberg, M., Eriksson, L., Jönsson, J., Sjöstróm, M., & Wold, S. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9700575 · Cited by 679 · see citing works
Rohrer, S. P., Birzin, E. T., Mosley, R. T., Berk, S. C., Hutchins, S. M., Shen, D., Xiong, Y., Hayes, E. C., Parmar, R. M., Foor, F., et al. (1998) · Science · doi:10.1126/science.282.5389.737 · Cited by 457 · see citing works
Prediction of Drug Binding Affinities by Comparative Binding Energy Analysis
Ortíz, Á. R., Pisabarro, M. T., Gago, F., & Wade, R. C. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00014a020 · Cited by 267 · see citing works
Computational methods for the structural alignment of molecules
Lemmen, C., & Lengauer, T. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008194019144 · Cited by 262 · see citing works
Modelling G-protein-coupled receptors for drug design
Flower, D. R. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(99)00006-4 · Cited by 249 · see citing works
VALIDATE: A New Method for the Receptor-Based Prediction of Binding Affinities of Novel Ligands
Head, R. D., Smythe, M. L., Oprea, T. I., Waller, C. L., Green, S. M., & Marshall, G. R. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9539002 · Cited by 247 · see citing works
Progress in protein structure prediction: Assessment of CASP3
Sternberg, M. J. E., Bates, P. A., Kelley, L. A., & MacCallum, R. M. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80050-5 · Cited by 119 · see citing works
Computational approaches to structure-based ligand design
Joseph‐McCarthy, D. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00031-5 · Cited by 100 · see citing works
So, S., & Karplus, M. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008073215919 · Cited by 64 · see citing works
Prūsis, P., Muceniece, R., Andersson, P. M., Post, C., Lundstedt, T., & Wikberg, J. E. S. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00249-1 · Cited by 46 · see citing works
Self-citationApostolakis, J., & Caflisch, A. (1999) · PubMed · Cited by 34 · see citing works
Apostolakist, J., & Caflisch, A. (1999) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207302666220203193501 · Cited by 31 · see citing works
α1-Adrenergic Receptor Subtype Determinants for 4-Piperidyl Oxazole Antagonists
Hamaguchi, N., True, T. A., Goetz, A. S., Stouffer, M. J., Lybrand, T. P., & Jeffs, P. W. (1998) · Biochemistry · doi:10.1021/bi972733a · Cited by 20 · see citing works
Flagged first, then by citations
1 of the 15 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913 · see citing works
T-cell epitope vaccine design by immunoinformatics
Patronov, A., & Doytchinova, I. A. (2013) · Open Biology · doi:10.1098/rsob.120139 · Cited by 426 · see citing works
Computational approaches in target identification and drug discovery
Κάτσιλα, Θ., Spyroulias, G. A., Patrinos, G. P., & Matsoukas, M. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.04.004 · Cited by 391 · see citing works
Koutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 285 · see citing works
Deep Learning in Virtual Screening: Recent Applications and Developments
Kimber, T. B., Chen, Y., & Volkamer, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094435 · Cited by 213 · see citing works
Machine learning models for drug–target interactions: current knowledge and future directions
D’Souza, S., Prema, K. V., & Balaji, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.003 · Cited by 208 · see citing works
van Westen, G. J. P., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W. T., & Bender, A. (2011) · MedChemComm · doi:10.1039/c0md00165a · Cited by 176 · see citing works
Basith, S., Cui, M., Macalino, S. J. Y., Park, J., Clavio, N. A. B., Kang, S., & Choi, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00128 · Cited by 140 · see citing works
Cadet, F., Fontaine, N., Li, G., Sanchis, J., Chong, M. N. F., Pandjaitan, R., Vetrivel, I., Offmann, B., & Reetz, M. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-35033-y · Cited by 132 · see citing works
Structure-Based Identification of OATP1B1/3 Inhibitors
Bruyn, T. D., van Westen, G. J. P., IJzerman, A. P., Stieger, B., de Witte, P. A. M., Augustijns, P., & Annaert, P. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084152 · Cited by 127 · see citing works
van Westen, G. J. P., Swier, R. F., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W., & Bender, A. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-41 · Cited by 124 · see citing works
Cortés‐Ciriano, I., Ain, Q. U., Subramanian, V., Lenselink, E. B., Méndez‐Lucio, O., IJzerman, A. P., Wohlfahrt, G., Prūsis, P., Malliavin, T. E., van Westen, G. J. P., et al. (2014) · MedChemComm · doi:10.1039/c4md00216d · Cited by 115 · see citing works
Rifaioğlu, A. S., Çetin-Atalay, R., Kahraman, D., Doğan, T., Martin, M. J., & Atalay, V. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa858 · Cited by 116 · see citing works
Lapins, M., Gutcaits, A., Prūsis, P., Post, C., Lundstedt, T., & Wikberg, J. E. S. (2002) · Protein Science · doi:10.1110/ps.2500102 · Cited by 112 · see citing works
Self-citationvan Westen, G. J. P., Swier, R. F., Cortés‐Ciriano, I., Wegner, J. K., Overington, J. P., IJzerman, A. P., van Vlijmen, H. W., & Bender, A. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-42 · Cited by 92 · see citing works
Lapins, M., Prūsis, P., Lundstedt, T., & Wikberg, J. E. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.6.1465 · Cited by 87 · see citing works
Self-citationWeill, N., & Rognan, D. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800447g · Cited by 86 · see citing works
Computational toxicology: an overview of the sources of data and of modelling methods
Nigsch, F., Macaluso, M., Mitchell, J. B. O., & Zmuidinavicius, D. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802660467 · Cited by 85 · see citing works
Exploring the epigenetic drug discovery landscape
Prachayasittikul, V., Prathipati, P., Pratiwi, R., Phanus‐umporn, C., Malik, A. A., Schaduangrat, N., Seenprachawong, K., Wongchitrat, P., Supokawej, A., Prachayasittikul, V., et al. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1295954 · Cited by 82 · see citing works
Self-citationLapins, M., Prūsis, P., Uhlén, S., & Wikberg, J. E. S. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti703 · Cited by 81 · see citing works
Self-citationProteochemometric modeling of HIV protease susceptibility
Lapins, M., Eklund, M., Spjuth, O., Prūsis, P., & Wikberg, J. E. S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-181 · Cited by 77 · see citing works
Self-citationWang, D. D., Zhu, M., & Yan, H. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa107 · Cited by 74 · see citing works
Peptide studies by means of principal properties of amino acids derived from MIF descriptors
Cruciani, G., Baroni, M., Carosati, E., Clementi, M., Valigi, R., & Clementi, S. (2004) · Journal of Chemometrics · doi:10.1002/cem.856 · Cited by 68 · see citing works
EpiTOP—a proteochemometric tool for MHC class II binding prediction
Dimitrov, I., Garnev, P., Flower, D. R., & Doytchinova, I. A. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq324 · Cited by 68 · see citing works
Large-Scale G Protein-Coupled Olfactory Receptor–Ligand Pairing
Cong, X., Ren, W., Pacalon, J., Xu, R., Xu, L., Li, X., de March, C. A., Matsunami, H., Yu, H., Yu, Y., et al. (2022) · ACS Central Science · doi:10.1021/acscentsci.1c01495 · Cited by 66 · see citing works
Binding Affinity Prediction with Property-Encoded Shape Distribution Signatures
Das, S., Krein, M. P., & Breneman, C. M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9004139 · Cited by 65 · see citing works
Current computational methods for predicting protein interactions of natural products
Moumbock, A. F. A., Li, J., Mishra, P., Gao, M., & Günther, S. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.08.008 · Cited by 58 · see citing works
Christmann‐Franck, S., van Westen, G. J. P., Papadatos, G., Escudie, F. B., Roberts, A., Overington, J. P., & Domine, D. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00122 · Cited by 55 · see citing works
van Westen, G. J. P., Wegner, J. K., Geluykens, P., Kwanten, L., Vereycken, I., Peeters, A., IJzerman, A. P., van Vlijmen, H., & Bender, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027518 · Cited by 54 · see citing works
Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases
Prūsis, P., Lapins, M., Yahorava, S., Petrovska, R., Niyomrattanakit, P., Katzenmeier, G., & Wikberg, J. E. S. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.081 · Cited by 55 · see citing works
Self-citationProteochemometrics – recent developments in bioactivity and selectivity modeling
Bongers, B. J., IJzerman, A. P., & Van Westen, G. J. P. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2020.08.003 · Cited by 54 · see citing works
van Westen, G. J. P., van den Hoven, O. O., van der Pijl, R., Mulder‐Krieger, T., de Vries, H., Wegner, J. K., IJzerman, A. P., van Vlijmen, H., & Bender, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003069 · Cited by 54 · see citing works
Schlessinger, A., Welch, M. A., van Vlijmen, H., Korzekwa, K., Swaan, P. W., & Matsson, P. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1174 · Cited by 53 · see citing works
Current advances in ligand‐based target prediction
Yang, S., Ye, Q., Ding, J., Yin, M., Lü, A., Chen, X., Hou, T., & Cao, D. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1504 · Cited by 52 · see citing works
Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery
Mansoldo, F. R. P., Carta, F., Angeli, A., Cardoso, V. D. S., Supuran, C. T., & Vermelho, A. B. (2020) · Molecules · doi:10.3390/molecules25225483 · Cited by 50 · see citing works
A Unified Proteochemometric Model for Prediction of Inhibition of Cytochrome P450 Isoforms
Lapins, M., Worachartcheewan, A., Spjuth, O., Georgiev, V., Prachayasittikul, V., Nantasenamat, C., & Wikberg, J. E. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066566 · Cited by 46 · see citing works
Self-citationQiu, T., Qiu, J., Feng, J., Wu, D., Yang, Y., Tang, K., Cao, Z., & Zhu, R. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw004 · Cited by 46 · see citing works
Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance
Rahman, M. M., Islam, M. R., Rahman, F., Rahaman, M. S., Khan, M. S., Abrar, S., Ray, T. K., Uddin, M. B., Kali, M. S. K., Dua, K., et al. (2022) · Bioengineering · doi:10.3390/bioengineering9080335 · Cited by 44 · see citing works
Prediction of indirect interactions in proteins
Prūsis, P., Uhlén, S., Petrovska, R., Lapins, M., & Wikberg, J. E. S. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-167 · Cited by 44 · see citing works
Self-citationAn improved approach for predicting drug–target interaction: proteochemometrics to molecular docking
Shaikh, N., Sharma, M. C., & Garg, P. (2016) · Molecular BioSystems · doi:10.1039/c5mb00650c · Cited by 44 · see citing works
Strömbergsson, H., Kryshtafovych, A., Prūsis, P., Fidelis, K. A., Wikberg, J. E. S., Komorowski, J., & Hvidsten, T. R. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21163 · Cited by 43 · see citing works
Self-citationUnbiased descriptor and parameter selection confirms the potential of proteochemometric modelling
Freyhult, E., Prūsis, P., Lapins, M., Wikberg, J. E. S., Moulton, V., & Gustafsson, M. G. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-50 · Cited by 42 · see citing works
Self-citationLapins, M., Veikšina, S., Uhlén, S., Petrovska, R., Mutule, I., Mutulis, F., Yahorava, S., Prūsis, P., & Wikberg, J. E. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002857 · Cited by 39 · see citing works
Self-citationPredictive in silico Off-Target Profiling in Drug Discovery
Schmidt, F., Matter, H., Heßler, G., & Czich, A. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.202 · Cited by 39 · see citing works
Computer-aided drug design: from discovery of novel pharmaceutical agents to systems pharmacology
Poroikov, V. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206601030 · Cited by 38 · see citing works
Strömbergsson, H., Daniluk, P., Kryshtafovych, A., Fidelis, K. A., Wikberg, J. E. S., Kleywegt, G. J., & Hvidsten, T. R. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800200e · Cited by 35 · see citing works
Self-citationRough set‐based proteochemometrics modeling of G‐protein‐coupled receptor‐ligand interactions
Strömbergsson, H., Prūsis, P., Midelfart, H., Lapins, M., Wikberg, J. E. S., & Komorowski, J. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20777 · Cited by 35 · see citing works
Self-citationPeptide binding to the HLA-DRB1 supertype: A proteochemometrics analysis
Dimitrov, I., Garnev, P., Flower, D. R., & Doytchinova, I. A. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.09.049 · Cited by 34 · see citing works
Fernández, M., Ahmad, S., & Sarai, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci1000532 · Cited by 33 · see citing works
Computational chemogenomics: Is it more than inductive transfer?
Brown, J. B., Okuno, Y., Marcou, G., Varnek, A. A., & Horvath, D. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9743-1 · Cited by 33 · see citing works
Multi-view self-attention for interpretable drug–target interaction prediction
Agyemang, B., Wu, W., Kpiebaareh, M. Y., Lei, Z., Nanor, E., & Chen, L. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103547 · Cited by 32 · see citing works
Junaid, M., Lapins, M., Eklund, M., Spjuth, O., & Wikberg, J. E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014353 · Cited by 31 · see citing works
Self-citationGlobal Free Energy Scoring Functions Based on Distance-Dependent Atom-Type Pair Descriptors
Krämer, C., & Gedeck, P. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100473d · Cited by 30 · see citing works
Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors
Prūsis, P., Lundstedt, T., & Wikberg, J. E. S. (2002) · Protein Engineering Design and Selection · doi:10.1093/protein/15.4.305 · Cited by 30 · see citing works
Self-citationStructural Modeling Extends QSAR Analysis of Antibody-Lysozyme Interactions to 3D-QSAR
Freyhult, E., Andersson, K., & Gustafsson, M. G. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)75032-2 · Cited by 29 · see citing works
Probing Receptor Structure/Function with Chimeric G-Protein-Coupled Receptors
Yin, D., Gavi, S., Wang, H., & Malbon, C. C. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1323 · Cited by 29 · see citing works
Computer-Aided Drug Design: from Discovery of Novel Pharmaceutical Agents to Systems Pharmacology
Poroikov, V. (2020) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750820030117 · Cited by 27 · see citing works
Personalized cancer immunotherapy using Systems Medicine approaches
Gupta, S. K., Jaitly, T., Schmitz, U., Schuler, G., Olaf Wolkenhauer, A., & Vera, J. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv046 · Cited by 26 · see citing works
Application of fourier transform and proteochemometrics principles to protein engineering
Cadet, F., Fontaine, N., Vetrivel, I., Chong, M. N. F., Savriama, O., Cadet, X. F., & Charton, P. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2407-8 · Cited by 25 · see citing works
van der Horst, E., Peironcely, J. E., van Westen, G. J. P., van den Hoven, O. O., Galloway, W. R. J. D., Spring, D. R., Wegner, J. K., van Vlijmen, H., IJzerman, A. P., Overington, J. P., et al. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611796391230 · Cited by 23 · see citing works
Proteo-chemometrics interaction fingerprints of protein–ligand complexes predict binding affinity
Wang, D. D., Xie, H., & Yan, H. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab132 · Cited by 23 · see citing works
Current methods for the prediction of T‐cell epitopes
Kar, P., Ruiz‐Perez, L., Arooj, M., & Mancera, R. L. (2018) · Peptide Science · doi:10.1002/pep2.24046 · Cited by 23 · see citing works
Study on human GPCR–inhibitor interactions by proteochemometric modeling
Gao, J. A., Huang, Q., Wu, D., Zhang, Q., Zhang, Y., Chen, T., Liu, Q., Zhu, R., Cao, Z., & He, Y. (2012) · Gene · doi:10.1016/j.gene.2012.11.061 · Cited by 22 · see citing works
Eberhardt, M., Lai, X., Tomar, N., Gupta, S. K., Schmeck, B., Steinkasserer, A., Schuler, G., & Vera, J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3283-2_9 · Cited by 21 · see citing works
Tresadern, G., Trabanco, A. A., Pérez‐Benito, L., Overington, J. P., van Vlijmen, H., & van Westen, G. J. P. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00338 · Cited by 20 · see citing works
Dixit, V. A., & Deshpande, S. (2016) · ChemistrySelect · doi:10.1002/slct.201601051 · Cited by 20 · see citing works
HyperPCM: Robust Task-Conditioned Modeling of Drug–Target Interactions
Svensson, E., Hoedt, P.-J., Hochreiter, S., & Klambauer, G. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01417 · Cited by 20 · see citing works
Melanocortin Receptors: Ligands and Proteochemometrics Modeling
Wikberg, J. E. S., Mutulis, F., Mutule, I., Veikšina, S., Lapins, M., Petrovska, R., & Prūsis, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03158.x · Cited by 19 · see citing works
Self-citationProteochemometric modelling of antibody-antigen interactions using SPOT synthesised peptide arrays
Mandrika, I., Prūsis, P., Yahorava, S., Shikhagaie, M., & Wikberg, J. E. S. (2007) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm022 · Cited by 19 · see citing works
Self-citationRasti, B., Karimi‐Jafari, M. H., & Ghasemi, J. B. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12759 · Cited by 18 · see citing works
Lapins, M., Prūsis, P., Petrovska, R., Uhlén, S., Mutule, I., Veikšina, S., & Wikberg, J. E. S. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21323 · Cited by 18 · see citing works
Self-citationKanakaveti, V., Anusuya, S., Ramakrishnan, C. V., Anoosha, P., Sakthivel, R., Rayala, S. K., & Gromiha, M. M. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.11.013 · Cited by 17 · see citing works
Proteochemometrics-Based Prediction of Peptide Binding to HLA-DP Proteins
Yordanov, V., Dimitrov, I., & Doytchinova, I. A. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00026 · Cited by 17 · see citing works
Ma, X., Chen, J., Lu, X., Zhe, Y., & Jiang, Z. (2021) · Journal of Separation Science · doi:10.1002/jssc.202001068 · Cited by 16 · see citing works
Willighagen, E., Wehrens, R., & Buydens, L. M. C. (2006) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408340600969601 · Cited by 16 · see citing works
Towards Proteome–Wide Interaction Models Using the Proteochemometrics Approach
Strömbergsson, H., Lapins, M., Kleywegt, G. J., & Wikberg, J. E. S. (2010) · Molecular Informatics · doi:10.1002/minf.201000052 · Cited by 15 · see citing works
Self-citationKontijevskis, A., Petrovska, R., Mutule, I., Uhlén, S., Komorowski, J., Prūsis, P., & Wikberg, J. E. S. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21461 · Cited by 15 · see citing works
Self-citationBaringhaus, K. H., & Matter, H. (2007) · Wiley eBooks · doi:10.1002/9783527619368.ch19 · Cited by 14 · see citing works
Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks
Kanev, G. K., Zhang, Y., Kooistra, A. J., Bender, A., Leurs, R., Bailey, D. S., Würdinger, T., de Graaf, C., de Esch, I. J. P., & Westerman, B. A. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011301 · Cited by 13 · see citing works
Rasti, B., Namazi, M., Karimi‐Jafari, M. H., & Ghasemi, J. B. (2016) · Molecular Informatics · doi:10.1002/minf.201600102 · Cited by 13 · see citing works
Nirmala, S., & Sudandiradoss, C. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.7.4167 · Cited by 13 · see citing works
Proteochemometric Modeling for Drug Repositioning
Schaduangrat, N., Anuwongcharoen, N., Phanus‐umporn, C., Sriwanichpoom, N., Wikberg, J. E. S., & Nantasenamat, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00010-9 · Cited by 13 · see citing works
Self-citationProteochemometric model for predicting the inhibition of penicillin-binding proteins
Nabu, S., Nantasenamat, C., Owasirikul, W., Lawung, R., Isarankura‐Na‐Ayudhya, C., Lapins, M., Wikberg, J. E. S., & Prachayasittikul, V. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9809-0 · Cited by 12 · see citing works
Self-citationα1 Adrenoceptor subtype selectivity
Balle, T., Andersen, K. V., Søby, K. K., & Liljefors, T. (2003) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(03)00120-7 · Cited by 12 · see citing works
Damavandi, S., Shiri, F., Emamjomeh, A., Pirhadi, S., & Beyzaei, H. (2023) · BMC Chemistry · doi:10.1186/s13065-023-00991-6 · Cited by 11 · see citing works
Fontaine, N., Cadet, X. F., & Vetrivel, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225640 · Cited by 11 · see citing works
Jia, L., Sun, T., Wang, Y., & Shen, Y. C. (2021) · BioMed Research International · doi:10.1155/2021/2593748 · Cited by 11 · see citing works
Chemogenomics: Looking at biology through the lens of chemistry
Doddareddy, M. R., van Westen, G. J. P., van der Horst, E., Peironcely, J. E., Corthals, F., IJzerman, A. P., Emmerich, M., Jenkins, J. L., & Bender, A. (2009) · Statistical Analysis and Data Mining The ASA Data Science Journal · doi:10.1002/sam.10046 · Cited by 11 · see citing works
Structural insights into the origin of phosphoinositide 3-kinase inhibition
Hariri, S., Rasti, B., Mirpour, M., Vaghar-Lahijani, G., Attar, F., & Shiri, F. (2020) · Structural Chemistry · doi:10.1007/s11224-020-01510-2 · Cited by 10 · see citing works
Davies, M. N., Gloriam, D. E. I., Secker, A., Freitas, A. A., Timmis, J., & Flower, D. R. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611796391221 · Cited by 10 · see citing works
Combining Bayesian and Evidential Uncertainty Quantification for Improved Bioactivity Modeling
Khalil, B., Schweighofer, K., Dyubankova, N., van Westen, G. J. P., & van Vlijmen, H. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01597 · Cited by 11 · see citing works
Qiu, T., Wu, D., Qiu, J., & Cao, Z. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0275-x · Cited by 8 · see citing works
Chemoinformatics Taking Biology into Account: Proteochemometrics
Wikberg, J. E. S., Spjuth, O., Eklund, M., & Lapins, M. (2011) · doi:10.1002/9781118131411.ch3 · Cited by 8 · see citing works
Self-citationRalchev, N., Markovski, A. M., Yankova, I. A., Manoylov, I. K., Doytchinova, I. A., Mihaylova, N., Shinkov, A. D., & Tchorbanov, A. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315083 · Cited by 7 · see citing works
QSAR of multiple mutated antibodies
Mandrika, I., Prūsis, P., Yahorava, S., Tārs, K., & Wikberg, J. E. S. (2007) · Journal of Molecular Recognition · doi:10.1002/jmr.817 · Cited by 7 · see citing works
Self-citationShoombuatong, W., Nabu, S., Simeon, S., Prachayasittikul, V., Lapins, M., Wikberg, J. E. S., & Nantasenamat, C. (2016) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2016.01.002 · Cited by 7 · see citing works
Self-citationProbing the origin of dihydrofolate reductase inhibition via proteochemometric modeling
Hariri, S., Ghasemi, J. B., Shirini, F., & Rasti, B. (2018) · Journal of Chemometrics · doi:10.1002/cem.3090 · Cited by 7 · see citing works
A Cohesive and Integrated Platform for Immunogenicity Prediction
Dimitrov, I., Atanasova, M., Patronov, A., Flower, D. R., & Doytchinova, I. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3389-1_50 · Cited by 7 · see citing works
Inferring molecular inhibition potency with AlphaFold predicted structures
Oliveira, P. F., Guedes, R. C., & Falcão, A. O. (2024) · Scientific Reports · doi:10.1038/s41598-024-58394-z · Cited by 6 · see citing works
Bioinformatics Tools for Predicting GPCR Gene Functions
Suwa, M. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7423-0_10 · Cited by 6 · see citing works
- Authors
- Lapinsh, M., Prusis, P., Gutcaits, A., Lundstedt, T., & Wikberg, J. E. S.
- Affiliations
- Uppsala University (SE)
- Corresponding author
- Wikberg, Jarl E.S.
- ORCID
- Wikberg, Jarl E.S.
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 1525
- Issue
- 1-2
- Pages
- 180-190
- ISSN
- 0304-4165 (ISSN-L)
- OpenAlex
- W2106440817
- Cited by
- 134
- References
- 15
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 13 · 2019: 5 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 4 · 2014: 6 · 2013: 7 · 2012: 3
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochimica et Biophysica Acta (BBA) - General Subjects (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- drug-receptor interactions, alpha1-adrenoceptors, receptor subtype selectivity, binding affinity prediction, ligand binding mechanism, rational drug design, receptor mutations
- MeSH terms
- Adrenergic alpha-Antagonists, Pharmaceutical Preparations, Humans, Ligands, Models, Biological, Oxazoles, Pharmacology, Receptors, Drug, Recombinant Fusion Proteins, Drug Design, Point Mutation, Receptors, Adrenergic, alpha-1, Quantitative Structure-Activity Relationship, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review